Nasal polyps

Russell A. Settipane, Anju T. Peters, Alexander G. Chiu

Research output: Contribution to journalArticlepeer-review


Nasal polyps occur in 1-4% of the population, usually occurring in the setting of an underlying local or systemic disease. The most common associated condition is chronic rhinosinusitis (CRS). A high prevalence of nasal polyps is also seen in allergic fungal rhinosinusitis, aspirin-exacerbated respiratory disease, Churg-Strauss syndrome, and cystic fibrosis. In the setting of CRS, nasal polyps are not likely to be cured by either medical or surgical therapy; however, control is generally attainable. The best medical evidence supports the use of intranasal corticosteroids for maintenance therapy and short courses of oral corticosteroids for exacerbations. The evidence for short- and long-term antibiotics is much less robust. For patients with symptomatic nasal polyposis nonresponsive to medical therapies, functional endoscopic sinus surgery provides an adjunctive therapeutic option.

Original languageEnglish (US)
JournalAmerican Journal of Rhinology and Allergy
Issue numberSUPPL.1
StatePublished - May 2013

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Immunology and Allergy


Dive into the research topics of 'Nasal polyps'. Together they form a unique fingerprint.

Cite this